首页> 美国卫生研究院文献>Postgraduate Medical Journal >Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.
【2h】

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.

机译:teprotide转换酶抑制过程中激素和血压的变化。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Changes induced by i.v. and subcutaneous teprotide in plasma renin, angiotensin I, angiotensin II, aldosterone and bradykinin were studied in a renal transplant patient with severe high renin hypertension, before and after trinephrectomy. The immediate reduction in BP produced by teprotide was not solely attributable to the inhibition of conversion of angiotensin I to angiotensin II, because there was also a transient increase in serum bradykinin; however, the prolonged antihypertensive effect of teprotide appeared independent of bradykinin. After trinephrectomy, teprotide lowered systolic BP but had no significant effect on diastolic BP or plasma bradykinin. beta-Blockade prevented the secondary increase in plasma renin which followed teprotide, thereby potentiating its anti-hypertensive effect.
机译:i.v.引起的变化在肾切除术前后,对患有严重高肾素高血压的肾移植患者进行了血浆肾素,血管紧张素I,血管紧张素II,醛固酮和缓激肽的皮下注射特罗普特的研究。由四肽所产生的BP立即降低不仅是由于抑制血管紧张素I向血管紧张素II的转化,还因为血清缓激肽的短暂增加。然而,teprotide的长期降压作用似乎与缓激肽无关。肾切除术后,teprotide降低了收缩压,但对舒张压或血浆缓激肽没有明显影响。 β-Blockade防止了继四肽后血浆中肾素的二次增加,从而增强了其抗高血压作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号